The clinical information of 12 patients can be found in Supplementary Table S2.The results revealed that tumor tissues with high ALG3 expression exhibited greater resistance to anti-PD-1 treatment, while tumor tissues with low ALG3 expression showed significantly reduced resistance (Figure 4B). Here, ALG3 is linked to neoplasm.